Literature DB >> 1679639

Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.

R Dolcetti1, S Pelucchi, R Maestro, S Rizzo, A Pastore, M Boiocchi.   

Abstract

Proto-oncogene restriction fragment length polymorphisms (RFLPs) were investigated in a group of 23 patients with squamous cell carcinomas of the larynx. The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders. In addition, the 2 patients heterozygous at the c-mos locus (TC-8 and TC-10) were the only 2 of our series of develop multiple malignancies. Also, the 10 kb L-myc allele was remarkably more represented in patients with laryngeal carcinoma when compared to controls. These findings suggest that c-mos and L-myc RFLPs might be helpful in identifying those individuals who are at a higher risk of developing laryngeal carcinomas. Single allele amplification of L-myc, c-myb and c-mos proto-oncogenes, with no concomitant mRNA hyperexpression, were observed in 3 cases. The results obtained seem to rule out a direct pathogenetic role of these proto-oncogenes and suggest that the amplification of other closely linked genes, located on chromosomes 1, 6 and 8, respectively, may be causally associated with the development of these tumors. No allelic deletions at the c-myb locus were observed, whereas a loss of a c-Ha-ras-1 allele was demonstrated in one of the 11 heterozygous patients. Thus, the analysis of polymorphic proto-oncogenes in laryngeal carcinomas allowed us to identify a group of genetic abnormalities (chromosomes 1, 6 and 8 gene amplifications and c-Ha-ras-1 deletions) which may be involved in the development or progression of these tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1679639     DOI: 10.1007/bf00176755

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  46 in total

1.  EcoRI RFLP linked to the human myb gene.

Authors:  C Dozier; S Walbaum; D Leprince; D Stehelin
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

2.  The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx and lung: a prospective study.

Authors:  D Schottenfeld; R C Gantt; E L Wyner
Journal:  Prev Med       Date:  1974-06       Impact factor: 4.018

3.  Multiple primary malignant tumors of the head and neck.

Authors:  A M Cohn; S B Peppard
Journal:  Am J Otolaryngol       Date:  1980-11       Impact factor: 1.808

4.  Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics.

Authors:  M J Cline; H Battifora
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

Review 5.  Transforming genes in human tumors.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; M Barbacid
Journal:  J Cell Biochem       Date:  1982       Impact factor: 4.429

Review 6.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

7.  Unique karyotypic abnormalities in a squamous cell carcinoma of the larynx.

Authors:  Y S Jin; N Mandahl; S Heim; A Biörklund; J Wennerberg; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1988-01

8.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer.

Authors:  M M Nau; B J Brooks; J Battey; E Sausville; A F Gazdar; I R Kirsch; O W McBride; V Bertness; G F Hollis; J D Minna
Journal:  Nature       Date:  1985 Nov 7-13       Impact factor: 49.962

9.  Presence of an allelic EcoRI restriction fragment of the c-mos locus in leukocyte and tumor cell DNAs of breast cancer patients.

Authors:  R Lidereau; D Mathieu-Mahul; C Theillet; M Renaud; M Mauchauffé; J Gest; C J Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls.

Authors:  G Chenevix-Trench; M Southall; C Kidson
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.